A Pharmacologically Immunosuppressed Mouse Model for Assessing Influenza B Virus Pathogenicity and Oseltamivir Treatment

Immunocompromised patients are highly susceptible to influenza virus infections. Although neuraminidase inhibitor (NAI) therapy has proved effective in these patients, the treatment regimens require optimization, which can be partly addressed via animal models. Here, we describe a pharmacologically...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Antiviral Res
Autors principals: Marathe, Bindumadhav M., Mostafa, Heba H., Vogel, Peter, Pascua, Philippe Noriel Q., Jones, Jeremy C., Russell, Charles J., Webby, Richard J., Govorkova, Elena A.
Format: Artigo
Idioma:Inglês
Publicat: 2017
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7202083/
https://ncbi.nlm.nih.gov/pubmed/29100887
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.antiviral.2017.10.021
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars